Quick Answer
INTEST CORP reported Cash and Equivalents of $14.22 million for fiscal year 2025.
INTEST CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $14.22M | -28.3% |
| 2024 | $19.83M | -56.2% |
| 2023 | $45.26M | +236.9% |
| 2022 | $13.43M | -36.6% |
| 2021 | $21.20M | +106.2% |
| 2020 | $10.28M | +35.0% |
| 2019 | $7.61M | -57.4% |
| 2018 | $17.86M | +34.4% |
| 2017 | $13.29M | -53.5% |
| 2016 | $28.61M | +11.3% |
| 2015 | $25.71M | +11.2% |
| 2014 | $23.13M | +21.6% |
| 2013 | $19.02M | +22.1% |
| 2012 | $15.58M | +11.6% |
| 2011 | $13.96M | +102.4% |
| 2010 | $6.89M | +160.5% |
| 2009 | $2.65M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.23M | -9.7% | -15.7% |
| June 30, 2025 | $19.25M | -5.5% | -12.7% |
| March 31, 2025 | $22.05M | -19.3% | +11.2% |
| December 31, 2024 | $19.83M | -56.2% | +10.3% |
| September 30, 2024 | $17.97M | -56.9% | -11.8% |
| June 30, 2024 | $20.37M | -45.6% | -25.5% |
| March 31, 2024 | $27.33M | +77.2% | -39.6% |
| December 31, 2023 | $45.26M | +236.9% | +8.6% |
- INTEST CORP showed a decrease of -28.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, INTEST CORP’s cash and equivalents has grown by 437.1% (from $2.65 million to $14.22 million).
- The most recent figure is from INTEST CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: